(3-Fluoro-4-methoxyphenyl)acetyl chloride, 95.0%, 1g

tert-butyl N-(4-oxo-1,4-dihydropyridin-2-yl)carbamate, 98%, 500mg

1-Bromo-4-methylpentane>98.0%(GC)25mL

Palmitoleic acid, 98.0%, 100g

(2S,3R,4S,5R,6R)-2-((6-fluoro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 95+%, 25mg

Ethyl 4-hydroxyquinoline-2-carboxylate, 95.0%, 250mg

N-[(1R*,4R*)-4-Aminocyclohexyl]isobutyramide hydrochloride, 1g

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate, 95%, 250mg

(S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene, 95.0%, 25g

7-Bromo-5-fluoro-2,3-dihydro-1H-inden-1-one, 95.0%, 250mg

Hexachloroplatinate de dihydrogène (IV), solution 5 g

(2-Ethynylphenyl)methanamine hydrochloride, 95.0%, 1g

Pyrrolo[2,1-f][1,2,4]triazine-2,4-dione, 95.0%, 5g